Table 2.
Ionization Cluster size distribution and Ion drift time analysis to confirm the breast malignancy.
| Parameters/Breast | Without Sample | Normal | Stage 0 | Stage 1 | Stage 2 | Stage 3a | Stage 3b | Stage 4 | |
|---|---|---|---|---|---|---|---|---|---|
| Ionization Cluster Size Distribution | Range | 0–3 | 713–715 | 1008–1010 | 1542–1543 | 2601–2603 | 3339–3402 | 3768–3701 | 6100–6102 |
| Mean | 2.6 | 714.7 | 1009.6 | 1542.8 | 2602.7 | 3395.5 | 3707.7 | 6101.8 | |
| б² | 0.84 | 0.41 | 0.44 | 0.16 | 0.41 | 0.85 | 0.81 | 0.36 | |
| б | 0.97 | 0.67 | 0.67 | 0.42 | 0.67 | 0.97 | 0.95 | 0.63 | |
| Times | — | — | 4.12 | 11.58 | 26.41 | 37.50 | 41.87 | 75.37 | |
| Ion Drift Time (µs) | Range | 6–7 | 16.3–16.5 | 41–43 | 44–46 | 49–50 | 61–61.5 | 90–91 | 98–99 |
| Mean | 6.9 | 16.47 | 42.7 | 45.7 | 49.9 | 61.45 | 90.9 | 98.9 | |
| б² | 0.09 | 0.0041 | 0.41 | 0.41 | 0.09 | 0.022 | 0.09 | 0.09 | |
| б | 0.32 | 0.067 | 0.67 | 0.67 | 0.32 | 0.16 | 0.32 | 0.32 | |
| Times | — | — | 15.92 | 17.74 | 20.29 | 27.31 | 45.19 | 50.04 | |
ICSD- Ionization Cluster Size Distribution; IDT- Ion Drift Time; б² - Variance; б - Standard Deviation; NMR – Normal to Malignancy Ratio.